Akcea Therapeutics Stock Quote AKCA - Stock Price, News, Charts, Message Board, Trades

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Akcea Therapeutics Inc (AKCA) Quote

Akcea Therapeutics Inc (AKCA)

18.17

0.00

(0.00%)

At close: March 02 4:00PM

Delayed by 15 minutes

18.17

0.00

( 0.00% )

After Hours: -

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

18.17

Bid

18.08

Ask

19.00

Volume

-

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

18.17

Open

-

Last Trade

Last Trade Time

Average Volume (3m)

-

Financial Volume

-

VWAP

-

Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product

Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product PR...

Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics

Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics Transaction creates a stronger, more...

WAYLIVRA▼® (volanesorsen), the First & Only Therapy for FCS, an Ultra-Rare & Life-Threatening Condition, to Be Available o...

National Institute for Health and Care Excellence (NICE) issues a positive recommendation for volanesorsen to treat adults with Familial...

Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics

Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics - Ionis to acquire remaining 24% of...

Positive Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L(Rx)) Presented at ESC Congress 2020

Positive Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L(Rx)) Presented at ESC Congress 2020 Results from Phase 2 study demonstrate patients...

Positive Phase 2 Clinical Data of AKCEA-APOCIII-L(Rx) Presented at ESC Congress 2020

Positive Phase 2 Clinical Data of AKCEA-APOCIII-L(Rx) Presented at ESC Congress 2020 Results in late-breaking...

Akcea and Ionis to Present Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L (Rx) ) at ESC Congress 2020

Akcea and Ionis to Present Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L (Rx) ) at ESC Congress...

Akcea and Ionis to Present Phase 2 Results of AKCEA-APOCIII-L(Rx) in Late-Breaking Presentation at ESC Congress 2020

Akcea and Ionis to Present Phase 2 Results of AKCEA-APOCIII-L(Rx) in Late-Breaking Presentation at ESC...

Akcea Announces New Pricing and Reimbursement of WAYLIVRA® (volanesorsen) in Germany

Akcea Announces New Pricing and Reimbursement of WAYLIVRA® (volanesorsen) in Germany WAYLIVRA is the only...

Akcea Reports Financial Results and Highlights for Second Quarter 2020

Akcea Reports Financial Results and Highlights for Second Quarter 2020 Global Net Product Revenues of $16...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

AKCA - Frequently Asked Questions (FAQ)

What is the current Akcea Therapeutics share price?

The current share price of Akcea Therapeutics is $ 18.17

What is the 1 year trading range for Akcea Therapeutics share price?

Akcea Therapeutics has traded in the range of $ 0.00 to $ 0.00 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
STAKSTAK Inc	$ 3.97 (156.13%)	173.35k
ORGOOrganogenesis Holdings Inc	$ 6.21 (102.28%)	58.69M
TRNRInteractive Strength Inc	$ 2.57 (67.97%)	192.48M
PMAXPowell Max Ltd	$ 0.511 (43.54%)	136.35M
ARBBARB IOT Group Ltd	$ 0.6635 (38.23%)	58.86M
NVNINVNI Group Ltd	$ 0.99 (-50.50%)	72.79M
SPGCSacks Parente Golf Inc	$ 0.2085 (-48.65%)	58.21M
ADGMAdagio Medical Holdings Inc	$ 0.8081 (-47.53%)	756.76k
PRAXPraxis Precision Medicines Inc	$ 38.60 (-40.64%)	3.2M
SAGSAG Holdings Ltd	$ 1.19 (-38.97%)	789.86k
NVDANVIDIA Corporation	$ 124.92 (3.97%)	389.48M
TRNRInteractive Strength Inc	$ 2.57 (67.97%)	193.57M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 13.44 (7.78%)	154.46M
PMAXPowell Max Ltd	$ 0.511 (43.54%)	137.18M
LCIDLucid Group Inc	$ 2.22 (-0.45%)	136.17M

Sidney

Sidney 7 years ago

Any thoughts on why so low today?

Thoro

Thoro 8 years ago

So Volatile. Any thoughts on why the big plunge today?

Rodney213

Rodney213 8 years ago

Like how clean the board is .Some heavy price target coverage today

dinosaurbob

dinosaurbob 8 years ago

Dropped heavy yesterday but bounced back some today. I am still up 17%, so I am not complaining.

Thoro

Thoro 8 years ago

This is a volatile stock. Its finding its legs.

dinosaurbob

dinosaurbob 8 years ago

Closed at $15.43 today up 47 cents.

dinosaurbob

dinosaurbob 8 years ago

Back up $1.02 today. This stock is like riding a roller coaster. Up one day and down the next. And big drops and rises too.

dinosaurbob

dinosaurbob 8 years ago

WTH happened today? Down $1.52!

dinosaurbob

dinosaurbob 8 years ago

Closed up 40 cents at $14.88

dinosaurbob

dinosaurbob 8 years ago

It was up big earlier but steadily dropping now. Still up 14 cents at 2:45 EST

Thoro

Thoro 8 years ago

AKCA, Akcea and Ionis Announce Submission of Marketing Authorization Application for Volanesorsen to the European Medicines Agency

https://ih.advfn.com/p.php?pid=nmona&article=75321782

dinosaurbob

dinosaurbob 8 years ago

Closed up at $14.48 (5.16%). Nice!

Thoro

Thoro 8 years ago

I know it dropped, but I like when it tests higher.

dinosaurbob

dinosaurbob 8 years ago

Yes, but it dropped to $13.77. I still believe in it though.

Thoro

Thoro 8 years ago

AKCA $16.30 looked great today!

dinosaurbob

dinosaurbob 8 years ago

I bought in at 9.88 and then doubled my portfolio Friday at $13.00. I see this over $20.00 by October!

Thoro

Thoro 8 years ago

AKCA

IPO doing great first 5 days of trading.

Thoro

Thoro 8 years ago

AKCA

#MARKET NEWS
JULY 14, 2017 / 12:12 PM / 3 DAYS AGO
BRIEF-Akcea Therapeutics Inc shares open at $8.13 in debut vs IPO price of $8/share

http://www.reuters.com/article/brief-akcea-therapeutics-inc-shares-open-idUSFWN1K50CZ

Thoro

Thoro 8 years ago

AKCA

#MARKET NEWS
JULY 13, 2017 / 8:30 PM / 4 DAYS AGO

BRIEF-Akcea Therapeutics says public offering of 15.6 mln common shares priced at $8 per share

http://www.reuters.com/article/brief-akcea-therapeutics-says-public-off-idUSASA09X2O

Akcea Therapeutics

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions